Skip to main content

Main menu

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
    • Continuing Education
    • JNM Podcasts
  • Subscriptions
    • Subscribers
    • Institutional and Non-member
    • Rates
    • Journal Claims
    • Corporate & Special Sales
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Reviewers
    • Permissions
    • Advertisers
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI

User menu

  • Subscribe
  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Journal of Nuclear Medicine
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI
  • Subscribe
  • My alerts
  • Log in
  • My Cart
Journal of Nuclear Medicine

Advanced Search

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
    • Continuing Education
    • JNM Podcasts
  • Subscriptions
    • Subscribers
    • Institutional and Non-member
    • Rates
    • Journal Claims
    • Corporate & Special Sales
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Reviewers
    • Permissions
    • Advertisers
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • View or Listen to JNM Podcast
  • Visit JNM on Facebook
  • Join JNM on LinkedIn
  • Follow JNM on Twitter
  • Subscribe to our RSS feeds
LetterLetters to the Editor

The Value of Functional PET in Quantifying Neurotransmitter Dynamics

Murray B. Reed, Matej Murgaš, Rupert Lanzenberger and Andreas Hahn
Journal of Nuclear Medicine May 2025, 66 (5) 824-825; DOI: https://doi.org/10.2967/jnumed.124.269238
Murray B. Reed
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Matej Murgaš
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Rupert Lanzenberger
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Andreas Hahn
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Info & Metrics
  • PDF
Loading

TO THE EDITOR: The investigation of neurotransmitter dynamics in response to stimulation is essential for understanding brain function and disorders. In vivo human brain research commonly uses PET with dopamine D2/3 receptor radioligands such as [11C]raclopride. Despite challenges in developing similar radioligands for the serotonin system (1), notable progress has been made with [11C]AZ10419369 (2) and [11C]Cimbi-36 (3), particularly for pharmacologic challenges.

In their recent work (4), Morris et al. provide a comprehensive review of approaches for time-variant neurotransmitter kinetics, offering valuable guidance for selecting or refining these techniques. These important approaches, based on the competition model, assume that the radiotracer competes with endogenously released neurotransmitter for postsynaptic receptor binding. Notably, the model is subject to a ceiling effect at about a 40% signal change, even for pharmacologic stimulation, for which neurotransmitter release may exceed 1,000%. Cognitive paradigms typically yield smaller signal changes (5%–15%).

As the work aimed to represent the state of the art (4), it is worth highlighting recent developments in functional PET (fPET) imaging. fPET uses repeated stimulation, which is isolated from baseline radiotracer uptake (5). Initially developed to image stimulation-induced changes in glucose metabolism with [18F]FDG, fPET has recently been adapted to the dopamine and serotonin neurotransmitter systems (6,7). The synthesis model underpinning fPET leverages the fact that neurotransmitter release is coupled with the corresponding synthesis process to replenish synaptic vesicles with de novo synthetized neurotransmitter. As the technique is still developing, the numeric relationships between neurotransmitter release and synthesis changes observed with fPET still need to be established. Also, current modeling is relatively simple, assuming a linear stimulation-induced increase in the time–activity curve, modeled with the general linear model and quantified with the Patlak plot. Nevertheless, this approach has proven particularly robust across various radiotracers and stimulation paradigms, with signal changes reaching about 100% for 6-[18F]FDOPA (7) and about 40% for [11C]AMT (6). Additionally, the high temporal resolution of fPET (seconds) supports the computation of molecular connectivity (8,9), which examines within-subject regional associations of PET dynamics rather than static, between-subject covariance. The simplicity of the technique, the strong signal changes, and the recently introduced fPET toolbox (10) together make fPET an accessible and effective approach for studying neurotransmitter dynamics, offering researchers easy and standardized access into this emerging field.

In conclusion, both the competition model and the synthesis model are pivotal for investigating neurotransmitter response. Although the former substantially benefitted from decades of refinement (4), emerging developments in fPET promise to expand the synthesis model’s capabilities, enabling a more detailed characterization of neurotransmitter signaling. Integrating these 2 approaches could further provide complementary perspectives, enriching our understanding of neurotransmitter dynamics.

DISCLOSURE

No potential conflict of interest relevant to this article was reported.

Murray B. Reed, Matej Murgaš, Rupert Lanzenberger*, Andreas Hahn

*Medical University of Vienna Vienna, Austria

E-mail: rupert.lanzenberger{at}meduniwien.ac.at

Footnotes

  • Published online Mar. 13, 2025.

  • © 2025 by the Society of Nuclear Medicine and Molecular Imaging.

REFERENCES

  1. 1.↵
    1. Paterson LM,
    2. Tyacke RJ,
    3. Nutt DJ,
    4. Knudsen GM
    . Measuring endogenous 5-HT release by emission tomography: promises and pitfalls. J Cereb Blood Flow Metab. 2010;30:1682–1706.
    OpenUrlCrossRefPubMed
  2. 2.↵
    1. Yang KC,
    2. Takano A,
    3. Halldin C,
    4. Farde L,
    5. Finnema SJ
    . Serotonin concentration enhancers at clinically relevant doses reduce [11C]AZ10419369 binding to the 5-HT(1B) receptors in the nonhuman primate brain. Transl Psychiatry. 2018;8:132.
    OpenUrlPubMed
  3. 3.↵
    1. Erritzoe D,
    2. Ashok AH,
    3. Searle GE,
    4. et al
    . Serotonin release measured in the human brain: a PET study with [11C]CIMBI-36 and d-amphetamine challenge. Neuropsychopharmacology. 2020;45:804–810.
    OpenUrlCrossRefPubMed
  4. 4.↵
    1. Morris ED,
    2. Emvalomenos GM,
    3. Hoye J,
    4. Meikle SR
    . Modeling PET data acquired during nonsteady conditions: what if brain conditions change during the scan? J Nucl Med. 2024;65:1824–1837.
    OpenUrlAbstract/FREE Full Text
  5. 5.↵
    1. Hahn A,
    2. Gryglewski G,
    3. Nics L,
    4. et al
    . Quantification of task-specific glucose metabolism with constant infusion of 18F-FDG. J Nucl Med. 2016;57:1933–1940.
    OpenUrlAbstract/FREE Full Text
  6. 6.↵
    1. Hahn A,
    2. Reed MB,
    3. Murgaš M,
    4. et al
    . Dynamics of human serotonin synthesis differentially link to reward anticipation and feedback. Mol Psychiatry. 2025;30:600–607.
    OpenUrlPubMed
  7. 7.↵
    1. Hahn A,
    2. Reed MB,
    3. Pichler V,
    4. et al
    . Functional dynamics of dopamine synthesis during monetary reward and punishment processing. J Cereb Blood Flow Metab. Nov 2021;41:2973–2985.
    OpenUrlCrossRefPubMed
  8. 8.↵
    1. Reed MB,
    2. Cocchi L,
    3. Knudsen GM,
    4. et al
    . Connecting the dots: approaching a standardized nomenclature for molecular connectivity combining data and literature. bioRxiv website. https://www.biorxiv.org/content/10.1101/2024.05.10.593490v1. Published May 10, 2024. Accessed February 24, 2025.
  9. 9.↵
    1. Reed MB,
    2. Ponce de León M,
    3. Vraka C,
    4. et al
    . Whole-body metabolic connectivity framework with functional PET. Neuroimage. 2023;271:120030.
    OpenUrlCrossRefPubMed
  10. 10.↵
    1. Hahn A,
    2. Reed MB,
    3. Milz C,
    4. Falb P,
    5. Murgaš M,
    6. Lanzenberger R
    . A unified approach for identifying PET-based neuronal activation and molecular connectivity with the functional PET toolbox. bioRxiv website. https://www.biorxiv.org/content/10.1101/2024.11.13.623377v1. Published November 14, 2024. Accessed February 24. 2025.
  • Received for publication November 28, 2024.
  • Accepted for publication December 5, 2024.
PreviousNext
Back to top

In this issue

Journal of Nuclear Medicine: 66 (5)
Journal of Nuclear Medicine
Vol. 66, Issue 5
May 1, 2025
  • Table of Contents
  • Table of Contents (PDF)
  • About the Cover
  • Index by author
  • Complete Issue (PDF)
Print
Download PDF
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for your interest in spreading the word on Journal of Nuclear Medicine.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
The Value of Functional PET in Quantifying Neurotransmitter Dynamics
(Your Name) has sent you a message from Journal of Nuclear Medicine
(Your Name) thought you would like to see the Journal of Nuclear Medicine web site.
Citation Tools
The Value of Functional PET in Quantifying Neurotransmitter Dynamics
Murray B. Reed, Matej Murgaš, Rupert Lanzenberger, Andreas Hahn
Journal of Nuclear Medicine May 2025, 66 (5) 824-825; DOI: 10.2967/jnumed.124.269238

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Share
The Value of Functional PET in Quantifying Neurotransmitter Dynamics
Murray B. Reed, Matej Murgaš, Rupert Lanzenberger, Andreas Hahn
Journal of Nuclear Medicine May 2025, 66 (5) 824-825; DOI: 10.2967/jnumed.124.269238
Twitter logo Facebook logo LinkedIn logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One
Bookmark this article

Jump to section

  • Article
    • DISCLOSURE
    • Footnotes
    • REFERENCES
  • Info & Metrics
  • PDF

Related Articles

  • No related articles found.
  • PubMed
  • Google Scholar

Cited By...

  • No citing articles found.
  • Google Scholar

More in this TOC Section

  • Business Model Beats Science and Logic: Dosimetry and Paucity of Its Use
  • Reply to “The Randomized, Phase 2 LuCAP Study”
  • Patient-Specific Dosimetry-Driven PRRT: Time to Move Forward!
Show more Letters to the Editor

Similar Articles

SNMMI

© 2025 SNMMI

Powered by HighWire